Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Elisabetta Loggi"'
Autor:
Elisabetta Loggi, Stefano Gitto, Filippo Gabrielli, Elena Franchi, Hajrie Seferi, Carmela Cursaro, Pietro Andreone
Publikováno v:
Viruses, Vol 14, Iss 7, p 1376 (2022)
More than 250 million people worldwide are currently infected with hepatitis B, despite the effectiveness of vaccination and other preventive measures. In terms of treatment, new therapeutic approaches are rapidly developing, promising to achieve the
Externí odkaz:
https://doaj.org/article/bbe4fedddb3e46b3bb241ff265cf1b19
Autor:
Stefano Gitto, Arrigo F.G. Cicero, Elisabetta Loggi, Marina Giovannini, Fabio Conti, Elena Grandini, Valeria Guarneri, Alessandra Scuteri, Giovanni Vitale, Carmela Cursaro, Claudio Borghi, Pietro Andreone
Publikováno v:
Annals of Hepatology, Vol 17, Iss 1, Pp 64-75 (2018)
Introduction. Host lipid metabolism influences viral replication and lifecycle of hepatitis C virus. Our aim was to evaluate changes in glucose and lipid metabolism of patients with chronic hepatitis C after therapy with direct acting antivirals (DAA
Externí odkaz:
https://doaj.org/article/a5a5a492a03045038dd6ff957e4a806a
Autor:
Elisabetta Loggi, Silvia Galli, Giovanni Vitale, Roberto Di Donato, Ranka Vukotic, Elena Grandini, Marzia Margotti, Valeria Guarneri, Giuliano Furlini, Claudio Galli, Maria Carla Re, Pietro Andreone
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0187755 (2017)
To evaluate the potential value of using a serological assay to quantitate the hepatitis C virus core antigen (HCV-Ag) when monitoring patients with chronic hepatitis C being treated with direct-acting antivirals (DAAs).Ninety-six patients treated wi
Externí odkaz:
https://doaj.org/article/bdde1149222f4ab28ab2385269a65868
Autor:
Fabio Conti, Ranka Vukotic, Stefania Lorenzini, Anna Riili, Carmela Cursaro, Alessandra Scuteri, Elisabetta Loggi, Silvia Galli, Giuliano Furlini, Mauro Bernardi, Pietro Andreone, MD.
Publikováno v:
Annals of Hepatology, Vol 13, Iss 2, Pp 196-203 (2014)
Background and aim. In patients with chronic hepatitis C receiving Peg interferon/ribavirin (PEG-IFN/RBV) who do not achieve ≥ 2log-reduction in HCV-RNA at week 12 (null responders, NR) and in those with ≥ 2log-decrease but detectable at week 24
Externí odkaz:
https://doaj.org/article/45fe2b76ec234ea88b126e010465c585
Autor:
Sirio Fiorino, Carmela Cursaro, Stefania Lorenzini, Elisabetta Loggi, Lucia Brodosi, Laura Cattani, Andrea Cuppini, Mauro Bernardi, Pietro Andreone
Publikováno v:
Italian Journal of Medicine, Vol 5, Iss 2, Pp 82-89 (2013)
Introduction: Different DNA and RNA viruses exploit common strategies to support their persistence and replication in infected individuals. In particular, the hepatitis B virus (HBV) and the hepatitis C virus (HCV) cause major health problems worldwi
Externí odkaz:
https://doaj.org/article/18455ed826734ccca2799af13bfe53cd
Autor:
Elisabetta Loggi, Florian K Bihl, Carmela Cursaro, Camilla Granieri, Silvia Galli, Lucia Brodosi, Giuliano Furlini, Mauro Bernardi, Christian Brander, Pietro Andreone
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e65327 (2013)
BACKGROUND AIMS: The immune impairment characterizing chronic hepatitis B (cHBV) infection is thought to be the consequence of persistent exposure to viral antigens. However, the immune correlates of different clinical stages of cHBV and their relati
Externí odkaz:
https://doaj.org/article/128e58ff178a49d8bec7e1a6ef127c9f
Publikováno v:
Microbiologia Medica, Vol 25, Iss 2 (2010)
Chlamydophila pneumoniae is an obligate intracellular pathogens, that causes multiple types of respiratory tract infections.The exposure to this pathogen is quite common. C. pneumoniae may cause a persistent infection in multiple organs and may be as
Externí odkaz:
https://doaj.org/article/d656ad57061c48348f7180a0ed0c2736
Autor:
Olivier Gasser, Florian K Bihl, Marcel Wolbers, Elisabetta Loggi, Ingrid Steffen, Hans H Hirsch, Huldrych F Günthard, Bruce D Walker, Christian Brander, Manuel Battegay, Christoph Hess, Swiss HIV Cohort Study
Publikováno v:
PLoS Medicine, Vol 4, Iss 3, p e96 (2007)
BACKGROUND: In chronic HIV infection, antiretroviral therapy-induced normalization of CD4(+) T cell counts (immune reconstitution [IR]) is associated with a decreased incidence of opportunistic diseases. However, some individuals remain at risk for o
Externí odkaz:
https://doaj.org/article/b6f51f1f87e0413fb62080db2a969a2e
Autor:
Barbara, Rossetti, Elisabetta, Loggi, Spertilli Raffaelli, Chiara, Simona, Mercinelli, Claudia Gandolfo, Gianni Gori Savellini, Silvia, Galli, Giovanni, Vitale, Roberto Di Donato, Ranka, Vukotic, Elena, Grandini, Marzia, Margotti, Valeria, Guarneri, Giuliano, Furlini, Maria Carla Re, Andrea De Luca, Pietro, Andreone, Claudio, Galli, MARIA GRAZIA CUSI
Publikováno v:
Università degli Studi di Siena-IRIS
Scopus-Elsevier
Scopus-Elsevier
Hepatitis C virus (HCV) Core Antigen (HCVAg) and HCV-RNA were tested in 962 plasma/serum samples from 180 patients during Direct Antiviral Agents (DAAs) treatment and at follow-up. One hundred and eighty individuals were included: 71% carried advance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::39aec65d9dafed37b821b71e0225557e
https://pubmed.ncbi.nlm.nih.gov/34151994
https://pubmed.ncbi.nlm.nih.gov/34151994
Autor:
Sirio Fiorino, Claudio Gallo, Maddalena Zippi, Paolo Emilio Orlandi, Roberta Pica, Dario de Biase, Michela Visani, Roberta Budriesi, Matteo Micucci, Federico Lari, Ivan Corazza, Fabio Tateo, Elisabetta Loggi, Wandong Hong
Publikováno v:
Future microbiology (Online) 16 (2021): 1105–1133. doi:10.2217/fmb-2021-0064
info:cnr-pdr/source/autori:Fiorino S.[1], Tateo F.[2], De Biase D.[3], Gallo C.G.[4], Orlandi P.E.[5], Corazza I.[6], Budriesi R.[7], Micucci M.[7], Visani M.[3], Loggi E.[8], Hong W.[9], Pica R.[10], Lari F.[1], Zippi M.[10]/titolo:SARS-CoV-2: Lessons from both the history of medicine and from the biological behavior of other well-known viruses/doi:10.2217%2Ffmb-2021-0064/rivista:Future microbiology (Online)/anno:2021/pagina_da:1105/pagina_a:1133/intervallo_pagine:1105–1133/volume:16
Future Microbiology
info:cnr-pdr/source/autori:Fiorino S.[1], Tateo F.[2], De Biase D.[3], Gallo C.G.[4], Orlandi P.E.[5], Corazza I.[6], Budriesi R.[7], Micucci M.[7], Visani M.[3], Loggi E.[8], Hong W.[9], Pica R.[10], Lari F.[1], Zippi M.[10]/titolo:SARS-CoV-2: Lessons from both the history of medicine and from the biological behavior of other well-known viruses/doi:10.2217%2Ffmb-2021-0064/rivista:Future microbiology (Online)/anno:2021/pagina_da:1105/pagina_a:1133/intervallo_pagine:1105–1133/volume:16
Future Microbiology
SARS-CoV-2 is the etiological agent of the current pandemic worldwide and its associated disease COVID-19. In this review, we have analyzed SARS-CoV-2 characteristics and those ones of other well-known RNA viruses viz. HIV, HCV and Influenza viruses,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03e854d106d64733504e5b3231785c0f
https://hdl.handle.net/11576/2696084
https://hdl.handle.net/11576/2696084
